Immunohistochemical study of semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 in the hippocampal vasculature: pathological synergy of Alzheimer's disease and diabetes mellitus (Q28269188)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Immunohistochemical study of semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 in the hippocampal vasculature: pathological synergy of Alzheimer's disease and diabetes mellitus	scientific article

Statements

scholarly article

0 references

Immunohistochemical study of semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 in the hippocampal vasculature: pathological synergy of Alzheimer's disease and diabetes mellitus (English)

0 references

Alzheimer's disease

1 reference

based on heuristic

inferred from title

immunohistochemistry

1 reference

based on heuristic

inferred from title

Alejandro Gella

object named as

Alejandro Gella

2

0 references

object named as

Montse Solé

3

0 references

object named as

Tony Valente

1

0 references

Mercedes Unzeta

object named as

Mercedes Unzeta

5

0 references

author name string

Núria Durany

4

0 references

language of work or name

0 references

publication date

October 2012

0 references

Journal of Neuroscience Research

0 references

90

0 references

10

0 references

1989-96

0 references

Vascular adhesion protein-1 in human ischaemic stroke

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23092

21 January 2018

VAP-1, Eotaxin3 and MIG as potential atherosclerotic triggers of severe calcified and stenotic human aortic valves: effects of statins

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23092

21 January 2018

Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23092

21 January 2018

Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23092

21 January 2018

Neuropathological stageing of Alzheimer-related changes

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23092

21 January 2018

Semicarbazide-sensitive amine oxidase (SSAO) from human and bovine cerebrovascular tissues: biochemical and immunohistological characterization.

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23092

21 January 2018

Potential inplications of endogenous aldehydes in beta-amyloid misfolding, oligomerization and fibrillogenesis

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23092

21 January 2018

Role of the Blood-Brain Barrier in the Pathogenesis of Alzheimers Disease

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23092

21 January 2018

RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23092

21 January 2018

LRP/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms.

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23092

21 January 2018

Human plasma semicarbazide sensitive amine oxidase (SSAO), beta-amyloid protein and aging

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23092

21 January 2018

AGES in brain ageing: AGE-inhibitors as neuroprotective and anti-dementia drugs?

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23092

21 January 2018

RAGE-dependent signaling in microglia contributes to neuroinflammation, Abeta accumulation, and impaired learning/memory in a mouse model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23092

21 January 2018

Overexpression of semicarbazide sensitive amine oxidase in the cerebral blood vessels in patients with Alzheimer's disease and cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23092

21 January 2018

Oxidative stress in Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23092

21 January 2018

Semicarbazide-sensitive amine oxidase in transgenic mice with diabetes

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23092

21 January 2018

Protein cross-linkage induced by formaldehyde derived from semicarbazide-sensitive amine oxidase-mediated deamination of methylamine.

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23092

21 January 2018

Soluble semicarbazide sensitive amine oxidase (SSAO) catalysis induces apoptosis in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23092

21 January 2018

Plasma VAP-1/SSAO activity predicts intracranial hemorrhages and adverse neurological outcome after tissue plasminogen activator treatment in stroke.

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23092

21 January 2018

VAP-1/SSAO plasma activity and brain expression in human hemorrhagic stroke

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23092

21 January 2018

Apoptosis signal-regulating kinase 1 in amyloid beta peptide-induced cerebral endothelial cell apoptosis.

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23092

21 January 2018

The case for blood-brain barrier dysfunction in the pathogenesis of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23092

21 January 2018

Serum semicarbazide-sensitive amine oxidase (SSAO) activity is an independent marker of carotid atherosclerosis.

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23092

21 January 2018

Differential effects of "Advanced glycation endproducts" and beta-amyloid peptide on glucose utilization and ATP levels in the neuronal cell line SH-SY5Y.

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23092

21 January 2018

Purification and characterization of membrane-bound semicarbazide-sensitive amine oxidase (SSAO) from bovine lung

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23092

21 January 2018

Hyperinsulinemia and risk of Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23092

21 January 2018

Mammalian plasma and tissue-bound semicarbazide-sensitive amine oxidases: biochemical, pharmacological and toxicological aspects

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23092

21 January 2018

Semicarbazide-sensitive amine oxidase in aortic smooth muscle cells mediates synthesis of a methylglyoxal-AGE: implications for vascular complications in diabetes

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23092

21 January 2018

Elevated serum semicarbazide-sensitive amine oxidase activity in non-insulin-dependent diabetes mellitus: correlation with body mass index and serum triglyceride.

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23092

21 January 2018

Glycoxidative stress creates a vicious cycle of neurodegeneration in Alzheimer's disease--a target for neuroprotective treatment strategies?

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23092

21 January 2018

Insulin-resistant brain state after intracerebroventricular streptozotocin injection exacerbates Alzheimer-like changes in Tg2576 AbetaPP-overexpressing mice

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23092

21 January 2018

Properties of a semicarbazide-sensitive amine oxidase in human umbilical artery.

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23092

21 January 2018

Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23092

21 January 2018

p53 phosphorylation is involved in vascular cell death induced by the catalytic activity of membrane-bound SSAO/VAP-1.

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23092

21 January 2018

Soluble semicarbazide-sensitive amine oxidase (SSAO) activity is related to oxidative stress and subchronic inflammation in streptozotocin-induced diabetic rats

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23092

21 January 2018

High-definition characterization of cerebral β-amyloid angiopathy in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23092

21 January 2018

Receptor for advanced glycation endproducts: a multiligand receptor magnifying cell stress in diverse pathologic settings

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23092

21 January 2018

Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Abeta deposition in an Alzheimer mouse model with diabetes

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23092

21 January 2018

Possible involvement of advanced glycation end-products (AGEs) in the pathogenesis of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23092

21 January 2018

Glycation in diabetic neuropathy: characteristics, consequences, causes, and therapeutic options

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23092

21 January 2018

Semicarbazide-sensitive amine oxidase (SSAO) and its possible contribution to vascular damage in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23092

21 January 2018

Immunohistochemical analysis of human brain suggests pathological synergism of Alzheimer's disease and diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23092

21 January 2018

Brain amyloid and Alzheimer disease

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23092

21 January 2018

Advanced glycation end products contribute to amyloidosis in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23092

21 January 2018

Danshensu ameliorates the cognitive decline in streptozotocin-induced diabetic mice by attenuating advanced glycation end product-mediated neuroinflammation.

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23092

21 January 2018

Insulin deficiency exacerbates cerebral amyloidosis and behavioral deficits in an Alzheimer transgenic mouse model

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23092

21 January 2018

Lipoprotein receptor-related protein-1 mediates amyloid-beta-mediated cell death of cerebrovascular cells

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23092

21 January 2018

RAGE and Alzheimer's disease: a progression factor for amyloid-beta-induced cellular perturbation?

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23092

21 January 2018

Mechanisms of disease: advanced glycation end-products and their receptor in inflammation and diabetes complications

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23092

21 January 2018

Involvement of cerebrovascular semicarbazide-sensitive amine oxidase in the pathogenesis of Alzheimer's disease and vascular dementia.

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23092

21 January 2018

Identifiers

10.1002/JNR.23092

0 references

PubMed publication ID

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28269188&oldid=1957126878"